These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31760467)

  • 1.
    Humbert O; Cadour N; Paquet M; Schiappa R; Poudenx M; Chardin D; Borchiellini D; Benisvy D; Ouvrier MJ; Zwarthoed C; Schiazza A; Ilie M; Ghalloussi H; Koulibaly PM; Darcourt J; Otto J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1158-1167. PubMed ID: 31760467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Masse M; Chardin D; Tricarico P; Ferrari V; Martin N; Otto J; Darcourt J; Comte V; Humbert O
    Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3696-3708. PubMed ID: 38896129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total metabolic tumor volume on
    Tricarico P; Chardin D; Martin N; Contu S; Hugonnet F; Otto J; Humbert O
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between
    Rossi G; Bauckneht M; Genova C; Rijavec E; Biello F; Mennella S; Dal Bello MG; Cittadini G; Bruzzi P; Piva R; Ceriani V; Sambuceti G; Lopci E; Morbelli S; Grossi F
    J Nucl Med; 2020 Jul; 61(7):990-998. PubMed ID: 31806768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What
    Turgeon GA; Iravani A; Akhurst T; Beaulieu A; Callahan JW; Bressel M; Cole AJ; Everitt SJ; Siva S; Hicks RJ; Ball DL; Mac Manus MP
    J Nucl Med; 2019 Mar; 60(3):328-334. PubMed ID: 30030343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT.
    Park S; Lee Y; Kim TS; Kim SK; Han JY
    Medicine (Baltimore); 2020 Dec; 99(51):e23815. PubMed ID: 33371161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods.
    Ayati N; Lee ST; Zakavi SR; Cheng M; Lau WFE; Parakh S; Pathmaraj K; Scott AM
    J Nucl Med; 2021 Jul; 62(7):926-933. PubMed ID: 33246978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunotherapy-induced organ inflammation assessed on
    Humbert O; Bauckneht M; Gal J; Paquet M; Chardin D; Rener D; Schiazza A; Genova C; Schiappa R; Zullo L; Rossi G; Martin N; Hugonnet F; Darcourt J; Morbelli S; Otto J
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3878-3891. PubMed ID: 35562529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy evaluation of neoadjuvant immunotherapy plus chemotherapy for non-small-cell lung cancer: comparison of PET/CT with postoperative pathology.
    Cheng Y; Chen ZY; Huang JJ; Shao D
    Eur Radiol; 2023 Oct; 33(10):6625-6635. PubMed ID: 37515634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
    Shang J; Ling X; Zhang L; Tang Y; Xiao Z; Cheng Y; Guo B; Gong J; Huang L; Xu H
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1945-53. PubMed ID: 27236466
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ito K; Kitajima K; Toriihara A; Ishibashi M; Nakahara T; Daisaki H; Ohe Y; Honda R; Kijima T; Hasegawa S; Nakajo M
    Ann Nucl Med; 2021 Nov; 35(11):1253-1263. PubMed ID: 34370219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of response to stereotactic body radiation therapy for nonsmall cell lung cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
    Han J; Song Q; Guo F; Du R; Fang H; Kang J; Lu Z
    Nucl Med Commun; 2022 Jun; 43(6):717-724. PubMed ID: 35354781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficiency of
    Tao X; Li N; Wu N; He J; Ying J; Gao S; Wang S; Wang J; Wang Z; Ling Y; Tang W; Zhang Z
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1209-1219. PubMed ID: 32043180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics of
    Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using
    Kitajima K; Watabe T; Nakajo M; Ishibashi M; Daisaki H; Soeda F; Tanemura A; Kanekura T; Yamazaki N; Ito K
    Jpn J Radiol; 2022 Jan; 40(1):75-85. PubMed ID: 34287739
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Fledelius J; Winther-Larsen A; Khalil AA; Bylov CM; Hjorthaug K; Bertelsen A; Frøkiær J; Meldgaard P
    J Nucl Med; 2017 Dec; 58(12):1931-1937. PubMed ID: 28490472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.
    Seban RD; Assie JB; Giroux-Leprieur E; Massiani MA; Soussan M; Bonardel G; Chouaid C; Playe M; Goldfarb L; Duchemann B; Girard N; Champion L
    Ann Nucl Med; 2020 Dec; 34(12):968-974. PubMed ID: 33070295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy.
    Evangelista L; Cuppari L; Menis J; Bonanno L; Reccia P; Frega S; Pasello G
    Nucl Med Commun; 2019 Aug; 40(8):802-807. PubMed ID: 31045745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.